FINWIRES · TerminalLIVE
FINWIRES

埃克森美孚预计第一季度产量将因中东冲突而受到影响

-- 埃克森美孚(XOM)预计,受中东冲突造成的生产中断影响,其全球油当量产量将在第一季度受到冲击。 根据埃克森美孚提交的监管文件,其位于卡塔尔和阿联酋的部分上游资产的生产自3月份起受到影响。袭击事件包括卡塔尔两条液化天然气(LNG)生产线遭到破坏。 该公司周三表示,这些中断可能导致埃克森美孚第一季度全球油当量产量环比下降约6%。 埃克森美孚表示:“公开报道显示,(生产线)受损需要较长时间才能修复。在进行现场评估之前,我们无法就两条生产线恢复正常运营所需的时间发表评论。” 根据该文件,中东资产约占该公司全球油当量产量的20%,但占上游业务收益的比例较小。 埃克森美孚表示,考虑到亚太地区原油供应减少的影响,预计其全球能源产品第一季度吞吐量将环比下降2%。 这家美国石油巨头的股价周三下跌5.8%。规模较小的竞争对手雪佛龙(CVX)的股价下跌5.6%。此前,美国和伊朗达成了为期两周的停火协议,导致原油价格暴跌。 埃克森美孚预计,在持续39天的美以战争结束后,能源价格将飙升,这将提振其第一季度上游业务的收益。该公司计划于5月1日公布第一季度业绩。 该公司表示:“预计第一季度每股收益将高于2025年第四季度,但需排除不利的时效性影响,这些影响会随着时间的推移而逆转。” 埃克森美孚表示,通常在价格上涨时期会出现不利的时效性影响。 该公司表示,由于原油和成品油交易的时间因素,第一季度能源产品收益可能会受到 33 亿美元至 41 亿美元的冲击。

Price: $154.13, Change: $-9.78, Percent Change: -5.97%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB